drugset / Trial / NCT01124760
Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The aim of this study is to examine the effect of coadministration of CYP3A4 inhibitors on the pharmacokinetics of AZD9742.
Timeline
- Start
- 2010-05
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD9742 | Unknown | 150 mg | Intravenous |
| Subject | Diltiazem | Small molecule | — | Oral |
| Subject | Ketoconazole | Small molecule | 200 mg | Oral |
Indications
No indication recorded.